To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Comparison between 0.125% and 0.25% bupivacaine ISBPB in rotator cuff repair

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
May 2013

Comparison between 0.125% and 0.25% bupivacaine ISBPB in rotator cuff repair

Vol: 2| Issue: 4| Number:190| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Diaphragm function after interscalene brachial plexus block: a double-blind, randomized comparison of 0.25% and 0.125% bupivacaine

J Shoulder Elbow Surg. 2013 Mar;22(3):381-6. doi: 10.1016/j.jse.2012.06.011. Epub 2012 Sep 1

Contributing Authors:
EM Thackeray JD Swenson MC Gertsch KM Phillips JW Steele RT Burks RZ Tashjian PE Greis

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

30 patients undergoing rotator cuff repair were randomized to receive ultrasound-guided interscalene brachial plexus block with either 20 mL of 0.125% bupivacaine or 0.25% bupivacaine, to compare the diaphragm function, oxygen saturation, and pain management outcomes between groups. Following evaluations over a 48 hour period, clinically similar pain management (VAS pain scores and opioid requirem...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.